Successful treatment of drug-induced acute liver failure with high-volume plasma exchange

Journal of Clinical Apheresis

Volumn 28, Issue 6, 2013, Pages 430-434

  Liu, Chung Te ^a   Chen, Tso Hsiao ^a   Cheng, Chung Yi ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

acute liver failure; artificial liver support; drug induced liver injury; plasma exchange

Indexed keywords

CIPROFLOXACIN; COLISTIN; ERTAPENEM; ETHAMBUTOL; FLUCONAZOLE; ISONIAZID; MEROPENEM; MICAFUNGIN; PIPERACILLIN PLUS TAZOBACTAM; PYRAZINAMIDE; RIFAMPICIN; TEICOPLANIN; TIGECYCLINE; TUBERCULOSTATIC AGENT;

ABDOMINAL SURGERY; ABNORMAL LABORATORY RESULT; ACINETOBACTER INFECTION; ACUTE KIDNEY FAILURE; ACUTE LIVER FAILURE; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSCIOUSNESS DISORDER; CONSCIOUSNESS LEVEL; DRUG WITHDRAWAL; DUODENUM ULCER; FEVER; FLUID RETENTION; GLASGOW COMA SCALE; HEMODIALYSIS; HEPATIC ENCEPHALOPATHY; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; HYPERBILIRUBINEMIA; INTENSIVE CARE UNIT; INTESTINE SURGERY; INTUBATION; JAUNDICE; LUNG TUBERCULOSIS; MALE; OLIGURIA; OUTCOME ASSESSMENT; PERITONITIS; PLASMA VOLUME; PLASMAPHERESIS; RESPIRATORY FAILURE; SENILE DEMENTIA; SEPTIC SHOCK; SHOCK; TOXIC HEPATITIS; ULCER PERFORATION;

ACUTE LIVER FAILURE; ARTIFICIAL LIVER SUPPORT; DRUG-INDUCED LIVER INJURY; PLASMA EXCHANGE;

AGED; AGED, 80 AND OVER; ANASTOMOTIC LEAK; ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; CROSS INFECTION; DRUG-INDUCED LIVER INJURY; DUODENAL ULCER; FATAL OUTCOME; HEPATIC ENCEPHALOPATHY; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; LIVER FAILURE; MALE; PERITONITIS; PLASMA; PLASMA EXCHANGE; PLASMA SUBSTITUTES; PNEUMONIA; SHOCK, SEPTIC; TUBERCULOSIS, PULMONARY;

EID: 84889682839     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.21291     Document Type: Article

References (27)

1. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM,. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Inter Med 2002; 137: 947-954.
2. Reuben A, Koch DG, Lee WM,. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010; 52: 2065-2076.
3. Fontana RJ, Seeff LB, Andrade RJ, Bjornsson E, Day CP, Serrano J, Hoofnagle JH,. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology 2010; 52: 730-742.
4. Ghabril M, Chalasani N, Bjornsson E,. Drug-induced liver injury: a clinical update. Curr Opin Gastroenterol 2010; 26: 222-226.
5. Stine JG, Lewis JH,. Drug-induced liver injury: a summary of recent advances. Expert Opin Drug Metabol Toxicol 2011; 7: 875-890.
6. Oppert M, Rademacher S, Petrasch K, Jorres A,. Extracorporeal liver support therapy with Prometheus in patients with liver failure in the intensive care unit. Ther Apher Dial 2009; 13: 426-430.
7. O'Grady JG, Schalm SW, Williams R,. Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273-275.
8. Redeker AG, Yamahiro HS,. Controlled trial of exchange-transfusion therapy in fulminant hepatitis. Lancet 1973; 1: 3-6.
9. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH,. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010; 25: 83-177.
10. Akdogan M, Camci C, Gurakar A, Gilcher R, Alamian S, Wright H, Nour B, Sebastian A,. The effect of total plasma exchange on fulminant hepatic failure. J Clin Apher 2006; 21: 96-99.
11. Clemmesen JO, Kondrup J, Nielsen LB, Larsen FS, Ott P,. Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure. Am J Gastroenterol 2001; 96: 1217-1223.
12. Schaefer B, Schaefer F, Engelmann G, Meyburg J, Heckert KH, Zorn M, Schmitt CP,. Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure. Nephrol Dial Transplant 2011; 26: 3633-3639.
13. Huang YK, Tan DM, Xie YT, Fan XG, Huang Y, Liu ZB, Li SL,. Randomized controlled study of plasma exchange combined with molecular adsorbent re-circulating system for the treatment of liver failure complicated with hepatic encephalopathy. Hepatogastroenterology 2012; 59: 1323-1326.
14. Larsen FS, Hansen BA, Jorgensen LG, Secher NH, Kirkegaard P, Tygstrup N,. High-volume plasmapheresis and acute liver transplantation in fulminant hepatic failure. Transplant Proc 1994; 26: 1788.
15. Larsen FS, Ejlersen E, Hansen BA, Mogensen T, Tygstrup N, Secher NH,. Systemic vascular resistance during high-volume plasmapheresis in patients with fulminant hepatic failure: relationship with oxygen consumption. Eur J Gastroenterol Hepatol 1995; 7: 887-892.
16. Kondrup J, Almdal T, Vilstrup H, Tygstrup N,. High volume plasma exchange in fulminant hepatic failure. Int J Artif Organs 1992; 15: 669-676.
17. De Silvestro G, Marson P, Brandolese R, Pittoni G, Ongaro G,. A single institution's experience (1982-1999) with plasma-exchange therapy in patients with fulminant hepatic failure. Int J Artif Organs 2000; 23: 454-461.
18. Lee WM,. Drug-induced hepatotoxicity. New Engl J Med 2003; 349: 474-485.
19. Adams DH, Ju C, Ramaiah SK, Uetrecht J, Jaeschke H,. Mechanisms of immune-mediated liver injury. Toxicol Sci 2010; 115: 307-321.
20. Jones DP, Lemasters JJ, Han D, Boelsterli UA, Kaplowitz N,. Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria. Mol Interv 2010; 10: 98-111.
21. Mao WL, Chen Y, Chen YM, Li LJ,. Changes of serum cytokine levels in patients with acute on chronic liver failure treated by plasma exchange. J Clin Gastroenterol 2011; 45: 551-555.
22. Mao WL, Lou YF, Ye B, Lin S, Chen YM, Chen Y,. Changes in peripheral CD4+CD25(high) regulatory T cells in the acute-on-chronic liver failure patients with plasma exchange treatment. Inflammation 2012; 35: 436-444.
23. Banares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, Saliba F, Sauerbruch T, Klammt S, Ockenga J, Pares A, Wendon J, Brunnler T, Kramer L, Mathurin P, de la Mata M, Gasbarrini A, Mullhaupt B, Wilmer A, Laleman W, Eefsen M, Sen S, Zipprich A, Tenorio T, Pavesi M, Schmidt HH, Mitzner S, Williams R, Arroyo V,. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology 2013; 57: 1153-1162.
24. Kribben A, Gerken G, Haag S, Herget-Rosenthal S, Treichel U, Betz C, Sarrazin C, Hoste E, Van Vlierberghe H, Escorsell A, Hafer C, Schreiner O, Galle PR, Mancini E, Caraceni P, Karvellas CJ, Salmhofer H, Knotek M, Gines P, Kozik-Jaromin J, Rifai K,. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology 2012; 142: 782-789.e783.
25. Pless G,. Artificial and bioartificial liver support. Organogenesis 2007; 3: 20-24.
26. Stadlbauer V, Krisper P, Aigner R, Haditsch B, Jung A, Lackner C, Stauber RE,. Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care 2006; 10: R169.
27. Rifai K, Ernst T, Kretschmer U, Haller H, Manns MP, Fliser D,. Removal selectivity of Prometheus: a new extracorporeal liver support device. World J Gastroenterol 2006; 12: 940-944.